Actively Recruiting
A Intervention for Reducing Sedentary Behaviour Among Prostate Cancer Survivors
Led by University of Toronto · Updated on 2024-12-04
120
Participants Needed
1
Research Sites
250 weeks
Total Duration
On this page
Sponsors
U
University of Toronto
Lead Sponsor
C
Canadian Institutes of Health Research (CIHR)
Collaborating Sponsor
AI-Summary
What this Trial Is About
This randomized controlled trial (RCT) will aim to examine the effect of a 12-week behavioural intervention on changing the sedentary behaviours (SB) of prostate cancer survivors (PCS) compared to a control group (FitBit-only group). PCS in the intervention group will receive a FitBit and 6 behavioural support sessions with a movement specialist guided by behavioural theory (i.e., the Multi-Process Action Control \[M-PAC\]). The FitBit-only group will only receive a FitBit and access to public health resources on physical activity (PA). The primary purpose of this study is to determine the efficacy of the intervention on changing SB of PCS immediately following the 12-week intervention and 6-months later. It is hypothesized that that the intervention will decrease their SB compared to the FitBit-only control condition at both timepoints. This trial will also examine the effect of the intervention on changing PA, motivational outcomes from the M-PAC framework, sleep quality, social support, physical function, quality of life, fatigue, disability and mental health compared to the active control condition.
CONDITIONS
Official Title
A Intervention for Reducing Sedentary Behaviour Among Prostate Cancer Survivors
Who Can Participate
Eligibility Criteria
You may qualify if you...
- 18 years of age or older
- Diagnosed with localized or asymptomatic metastatic primary prostate cancer
- Not currently receiving radiation or chemotherapy
- Ability to speak and understand English
- Less than 150 minutes of moderate-to-vigorous physical activity per week
- More than 8 hours of sedentary behavior daily
- In the contemplation or preparation stage to change physical activity behavior
- Access to a smartphone, tablet, or computer
- No cardiac contraindications such as unstable angina, arrhythmia, heart failure, or aortic stenosis
- Medical clearance from a primary health care provider if necessary
- Currently living in Canada
You will not qualify if you...
- Not planning to live in Canada for the next 12 months
- Medical conditions that prevent walking, such as severe knee or hip arthritis
- Presence of other primary or recurrent invasive cancer except non-melanoma skin cancer
- Experienced a fall within the last 12 months
- Currently using a gait aid device
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University of Toronto
Toronto, Ontario, Canada, M5S 2W6
Actively Recruiting
Research Team
L
Linda Trinh, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here